Diagnostic Utility of the URiSCAN 2 ACR Strip as a Point-of-care Test for Estimating Urine Albumin-Creatinine Ratios.
- Author:
Jimyung KIM
1
;
Jinsook LIM
;
Sun Hoe KOO
;
Gye Cheol KWON
Author Information
- Publication Type:Original Article
- Keywords: Albuminuria; Albumin-creatinine ratio; Kidney disease; Point-of-care testing; Random urine
- MeSH: Albuminuria; Creatinine; Humans; Hypertension; Kidney Diseases; Sensitivity and Specificity
- From:Laboratory Medicine Online 2014;4(3):140-145
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: Diagnosing albuminuria by measuring the urinary albumin-creatinine ratios (UACR) is important for the early detection of kidney diseases in patients with diabetes or hypertension. Currently, a few point-of-care testing (POCT) systems exist for estimating the UACR. Here, we evaluated the performance characteristics of two semi-quantitative UACR POCT assays. METHODS: Albumin and creatinine levels were quantified for 219 randomly acquired urine samples with the Toshiba TBA-200FR NEO analyzer, and the UACR were calculated. The results were compared to UACR measured using the CLINITEK Microalbumin 2 Strip (Siemens, USA) and URiSCAN 2 ACR Strip (YD diagnostics, Korea) POCT assays. RESULTS: Semi-quantitative results from the CLINITEK and URiSCAN UACR assays showed that the sensitivity and specificity of each test were, respectively, 96.7% and 62.7%, and 45.9% and 84.8%. Positive and negative predictive values of the CLINITEK and URiSCAN tests were, respectively, 50.0% and 98.0%, and 53.8% and 80.2%. The rate of agreement between URiSCAN test and CLINITEK test was 91.1% in the normal UACR range (<30 mg/g), but it was as low as 36.4% in the abnormal UACR range (> or =30 mg/g). CONCLUSIONS: The URiSCAN test showed higher specificity than did the CLINITEK test owing to the lower false positive results. However, the high rate of false negatives for the URiSCAN test significantly lowered its sensitivity and negative predictive values. Therefore, the sensitivity of the URiSCAN device in detecting urine albumin needs to be improved before its adoption as a reliable rule-out testing system.
